These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 27521363)

  • 1. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
    Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
    J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis.
    Borgdorff H; Armstrong SD; Tytgat HL; Xia D; Ndayisaba GF; Wastling JM; van de Wijgert JH
    PLoS One; 2016; 11(3):e0150767. PubMed ID: 26963809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
    Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
    Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
    Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
    PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women.
    Borgdorff H; Tsivtsivadze E; Verhelst R; Marzorati M; Jurriaans S; Ndayisaba GF; Schuren FH; van de Wijgert JH
    ISME J; 2014 Sep; 8(9):1781-93. PubMed ID: 24599071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.
    Shannon B; Gajer P; Yi TJ; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Kaul R
    J Infect Dis; 2017 May; 215(9):1366-1375. PubMed ID: 28201724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial colonization and beta defensins in the female genital tract in HIV infection.
    Jiang W; Ghosh SK; Flyckt R; Kalinowska M; Starks D; Jurevic R; Weinberg A; Lederman MM; Rodriguez B
    Curr HIV Res; 2012 Sep; 10(6):504-12. PubMed ID: 22716110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women.
    Watts DH; Fazzari M; Minkoff H; Hillier SL; Sha B; Glesby M; Levine AM; Burk R; Palefsky JM; Moxley M; Ahdieh-Grant L; Strickler HD
    J Infect Dis; 2005 Apr; 191(7):1129-39. PubMed ID: 15747249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal flora in HPV infection: a cross‑sectional analysis.
    Dou P; Fang F; Qin R; Nie J; Chen X; Yin X; Wang Y; Shi S
    J Obstet Gynaecol; 2024 Dec; 44(1):2361847. PubMed ID: 38861397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial vaginosis, human papilloma virus and herpes viridae do not predict vaginal HIV RNA shedding in women living with HIV in Denmark.
    Wessman M; Thorsteinsson K; Jensen JS; Storgaard M; Rönsholt FF; Johansen IS; Pedersen G; Nørregård Nielsen L; Bonde J; Katzenstein TL; Weis N; Lebech AM
    BMC Infect Dis; 2017 May; 17(1):376. PubMed ID: 28569142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
    Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK
    mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
    Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R
    Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection.
    Onywera H; Anejo-Okopi J; Mwapagha LM; Okendo J; Williamson AL
    PLoS One; 2021; 16(6):e0253218. PubMed ID: 34143825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
    Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.
    Mitchell C; Balkus JE; Fredricks D; Liu C; McKernan-Mullin J; Frenkel LM; Mwachari C; Luque A; Cohn SE; Cohen CR; Coombs R; Hitti J
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):13-9. PubMed ID: 23020644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervicovaginal microbiota composition correlates with the acquisition of high-risk human papillomavirus types.
    Huang X; Li C; Li F; Zhao J; Wan X; Wang K
    Int J Cancer; 2018 Aug; 143(3):621-634. PubMed ID: 29479697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus molecular prevalence in south China and the impact on vaginal microbiome of unvaccinated women.
    Wang T; Li W; Cai M; Ji S; Wang Y; Huang N; Jiang Y; Zhang Z
    mSystems; 2024 Sep; 9(9):e0073824. PubMed ID: 39120153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women.
    Buckley N; Huber A; Lo Y; Castle PE; Kemal K; Burk RD; Strickler HD; Einstein MH; Young M; Anastos K; Herold BC
    Am J Reprod Immunol; 2016 Feb; 75(2):146-54. PubMed ID: 26685115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis.
    Borgogna JC; Shardell MD; Santori EK; Nelson TM; Rath JM; Glover ED; Ravel J; Gravitt PE; Yeoman CJ; Brotman RM
    BJOG; 2020 Jan; 127(2):182-192. PubMed ID: 31749298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.